Frontiers in pharmacology
Oliceridine and morphine differentially modulate the gut microbiota-intestinal barrier axis in a rat postoperative pain model
Door Li K, Jiang S, Huang P en 5 anderen.
Inhoud in het Engels
Abstract
Background
Oliceridine is a novel G protein-biased μ-opioid receptor agonist with potentially improved gastrointestinal tolerability compared with conventional opioids. However, its impact on postoperative intestinal homeostasis-specifically the gut microbiota and intestinal barrier-remains poorly understood.
Methods
A postoperative pain model was established in male Sprague-Dawley rats using the Brennan plantar incision method. Animals were randomly assigned to four groups: non-incision control (CON), plantar incision plus normal saline, plantar incision plus oliceridine (OLI, 1 mg/kg subcutaneous bolus followed by continuous infusion at 1 mg/kg/day for 72 h), and plantar incision plus morphine (MF, 5 mg/kg subcutaneous bolus followed by continuous infusion at 5 mg/kg/day for 72 h). Analgesic efficacy was assessed by mechanical withdrawal threshold (MWT) and area under the curve (AUC). Intestinal morphology, epithelial Claudin-1 expression by immunofluorescence (n = 4 per group), gut microbiota composition (16S rRNA gene sequencing, n = 6 per group), and host ileal transcriptomic profiles (RNA-seq, n = 3 per group) were evaluated.